Ani Pharmaceuticals Ratios (2010-2026) | ANIP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	54.11%	53.11%	44.36%	46.85%	52.21%	60.76%	61.45%	64.69%	63.72%	63.51%	59.42%	64.23%	58.20%	57.48%	57.87%	62.95%	64.70%	59.01%	59.42%	60.59%
EBT Margin (Quarter)	-37.43%	-13.64%	-50.64%	-40.17%	-25.48%	-14.58%	-6.12%	2.03%	4.50%	8.73%	0.72%	18.43%	-1.66%	-21.23%	-7.22%	10.14%	4.98%	14.84%	12.74%	16.94%
EBIT Margin (Quarter)	-31.99%	-6.84%	-38.94%	-29.77%	-17.48%	-5.96%	1.93%	9.27%	10.64%	13.61%	5.11%	14.78%	3.74%	-13.83%	-2.30%	13.29%	6.57%	15.91%	14.07%	16.38%
EBITDA Margin (Quarter)	-31.99%	-6.84%	-38.94%	-29.77%	-17.48%	-5.96%	1.93%	9.27%	10.64%	13.61%	5.11%	14.78%	3.74%	-13.83%	-2.30%	13.29%	6.57%	15.91%	14.07%	16.38%
Operating Margin (Quarter)	-31.99%	-6.84%	-38.94%	-29.77%	-17.48%	-5.96%	1.93%	9.27%	10.64%	13.61%	5.11%	14.78%	3.74%	-13.83%	-2.30%	13.29%	6.57%	15.91%	14.07%	16.38%
Net Margin (Quarter)	-29.01%	-8.54%	-39.93%	-31.85%	-20.76%	-10.74%	-4.93%	0.97%	5.01%	7.23%	0.57%	12.95%	-1.95%	-16.57%	-5.61%	7.75%	3.85%	11.53%	11.13%	12.42%
FCF Margin (Quarter)	-1.42%	-7.30%	-20.20%	-29.77%	-16.26%	5.01%	-4.93%	17.86%	15.55%	27.89%	33.92%	12.40%	12.33%	0.17%	15.31%	17.23%	33.28%	16.66%	16.96%	22.02%
Efficiency
Inventory Average (Quarter)	69.25M	70.01M	74.30M	82.42M	91.78M	102.87M	105.34M	104.50M	103.99M	105.46M	108.89M	112.52M	119.64M	136.75M	142.41M	137.09M	137.86M	142.40M	144.77M	143.27M
Assets Average (Quarter)	472.00M	475.31M	621.03M	758.22M	748.09M	745.22M	749.60M	762.66M	812.28M	874.63M	897.17M	909.47M	917.64M	1,104.07M	1,285.92M	1,288.45M	1,317.71M	1,375.58M	1,424.26M	1,431.17M
Equity Average (Quarter)		191.66M	275.07M	352.42M	341.53M	336.82M	337.61M	339.01M
Invested Capital (Quarter)	207.10M	207.33M	359.59M	346.94M	337.81M	337.52M	338.54M	340.33M	0.85M	0.85M	12.27M	0.41M	0.84M	1.28M	9.17M	11.19M	0.48M	15.24M	17.27M	19.30M
Asset Utilization Ratio (Quarter)	0.36	0.36	0.28	0.30	0.34	0.38	0.42	0.47	0.49	0.51	0.54	0.57	0.59	0.50	0.48	0.52	0.57	0.60	0.62	0.65
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-0.52	-0.12	-3.94	-0.56	-0.37	-0.14	0.24	0.43	0.53	0.75	0.55	1.11	0.28	-0.40	-0.85	0.57	0.29	0.75	3.39	1.01
Debt to Equity (Quarter)	1.07	1.06	0.80	0.83	0.85	0.85	0.84	0.84
Debt Ratio (Quarter)	0.43	0.43	0.37	0.39	0.38	0.39	0.38	0.37	0.33	0.32	0.33	0.31	0.31	0.24	0.25	0.24	0.22	0.22	0.21	0.21
Equity Ratio (Quarter)	0.40	0.41	0.46	0.46	0.45	0.46	0.45	0.44
Times Interest Earned (Quarter)	-0.52	-0.12	-3.94	-0.56	-0.37	-0.14	0.24	0.43	0.53	0.75	0.55	1.11	0.28	-0.40	-0.85	0.57	0.29	0.75	3.39	1.01
Dividends & Payouts
FCF Payout Ratio (Quarter)			-0.02	-0.02	-0.03	0.10	-0.09	0.02	0.02	0.01	0.01	0.02	0.02	1.62	0.01	0.01	0.01	0.01
Valuation
Enterprise Value (Quarter)	-24.26M	-15.25M	-105.30M	-81.91M	-68.39M	-61.28M	-53.23M	-67.76M	-161.71M	-193.08M	-221.12M	-228.60M	-240.11M	-145.02M	-144.89M	-149.84M	-217.83M	-262.65M	-285.62M	-311.21M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-2.45%	-4.03%	-7.46%	-9.14%	-9.11%	-9.17%	-5.43%	-0.97%	2.77%	5.68%	6.25%	7.43%	6.45%	1.28%	0.05%	0.60%	1.41%	6.51%	9.69%	10.39%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.02%	0.02%	0.03%	0.01%	0.00%	0.00%	0.00%	0.02%	0.02%	0.02%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Developers

Ani Pharmaceuticals Ratios (2010-2026) | ANIP

Research Tools

Developers

Ani Pharmaceuticals Ratios (2010-2026) | ANIP

Create an account

Sign In

Reset Password